Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes

被引:67
作者
Zhang, Dongjuan [1 ,2 ]
Yang, Hang [1 ,2 ]
Kong, Xiaomu [1 ,2 ]
Wang, Kang [1 ]
Mao, Xuan [4 ]
Yan, Xianzhong [4 ]
Wang, Yuan [3 ]
Liu, Siqi [3 ]
Zhang, Xiaoyan [1 ,2 ]
Li, Jing [1 ,2 ]
Chen, Lihong [1 ,2 ]
Wu, Jing [1 ,2 ]
Wei, Mingfen [1 ,2 ]
Yang, Jichun [1 ,2 ]
Guan, Youfei [1 ,2 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 1000191, Peoples R China
[2] Chinese Acad Sci, Key Lab Cardiovasc Sci, Minist Educ, Beijing, Peoples R China
[3] Chinese Acad Sci, Beijing Genom Inst, Beijing, Peoples R China
[4] Natl Ctr Biomed Anal, Beijing, Peoples R China
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2011年 / 300卷 / 02期
关键词
diabetic nephropathy; ketone body; gene expression; epithelial-to-mesenchymal transition; MITOCHONDRIAL 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE; EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX GENE-EXPRESSION; 2-DIMENSIONAL ELECTROPHORESIS; BETA-HYDROXYBUTYRATE; RENAL STRUCTURE; PPAR-ALPHA; TGF-BETA; NEPHROPATHY; MICE;
D O I
10.1152/ajpendo.00308.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Zhang D, Yang H, Kong X, Wang K, Mao X, Yan X, Wang Y, Liu S, Zhang X, Li J, Chen L, Wu J, Wei M, Yang J, Guan Y. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am J Physiol Endocrinol Metab 300: E287-E295, 2011. First published October 19, 2010; doi: 10.1152/ajpendo.00308.2010.-Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. To date, the molecular mechanisms of DN remain largely unclear. The present study aimed to identify and characterize novel proteins involved in the development of DN by a proteomic approach. Proteomic analysis revealed that 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase 2 (HMGCS2), the key enzyme in ketogenesis, was increased fourfold in the kidneys of type 2 diabetic db/db mice. Consistently, the activity of HMGCS2 in kidneys and 24-h urinary excretion of the ketone body beta-hydroxybutyrate (beta-HB) were significantly increased in db/db mice. Immunohistochemistry, immunofluorescence, and real-time PCR studies further demonstrated that HMGCS2 was highly expressed in renal glomeruli of db/db mice, with weak expression in the kidneys of control mice. Because filtered ketone bodies are mainly reabsorbed in the proximal tubules, we used RPTC cells, a rat proximal tubule cell line, to examine the effect of the increased level of ketone bodies. Treating cultured RPTC cells with 1 mM beta-HB significantly induced transforming growth factor-beta 1 expression, with a marked increase in collagen I expression. beta-HB treatment also resulted in a marked increase in vimentin protein expression and a significant reduction in E-cadherin protein levels, suggesting an enhanced epithelial-to-mesenchymal transition in RPTCs. Collectively, these findings demonstrate that diabetic kidneys exhibit excess ketogenic activity resulting from increased HMGCS2 expression. Enhanced ketone body production in the diabetic kidney may represent a novel mechanism involved in the pathogenesis of DN.
引用
收藏
页码:E287 / E295
页数:9
相关论文
共 51 条
[1]   Use of genetic mouse models in the study of diabetic nephropathy [J].
Allen T.J. ;
Cooper M.E. ;
Lan H.Y. .
Current Diabetes Reports, 2004, 4 (6) :435-440
[2]   Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice [J].
Barati, Michelle T. ;
Merchant, Michael L. ;
Kain, Angela B. ;
Jevans, Anthony W. ;
McLeish, Kenneth R. ;
Klein, Jon B. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 293 (04) :F1157-F1165
[3]   Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice [J].
Begriche, Karima ;
Letteron, Philippe ;
Abbey-Toby, Adje ;
Vadrot, Nathalie ;
Robin, Marie-Anne ;
Bado, Andre ;
Pessayre, Dominique ;
Fromenty, Bernard .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (05) :E939-E951
[4]  
Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]
[5]   Peroxisome proliferator-activated receptor α/γ dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice [J].
Cha, Dae Ryong ;
Zhang, Xiaoyan ;
Zhang, Yahua ;
Wu, Jing ;
Su, Dongming ;
Han, Jee Young ;
Fang, Xuefen ;
Yu, Bo ;
Breyer, Matthew D. ;
Guan, Youfei .
DIABETES, 2007, 56 (08) :2036-2045
[6]   Quantitative 1H NMR spectroscopy of blood plasma metabolites [J].
de Graaf, RA ;
Behar, KL .
ANALYTICAL CHEMISTRY, 2003, 75 (09) :2100-2104
[7]   The pathogenesis of diabetic nephropathy [J].
Dronavalli, Suma ;
Duka, Irena ;
Bakris, George L. .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (08) :444-452
[8]   TRANSPORT OF BETA-HYDROXYBUTYRATE AND ACETOACETATE ALONG RAT NEPHRONS - A MICROPUNCTURE STUDY [J].
FERRIER, B ;
MARTIN, M ;
JANBON, B ;
BAVEREL, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05) :F762-F769
[9]   β-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-β and Smad3 [J].
Guh, JY ;
Chuang, TD ;
Chen, HC ;
Hung, WC ;
Lai, YH ;
Shin, SJ ;
Chuang, LY .
KIDNEY INTERNATIONAL, 2003, 64 (06) :2041-2051
[10]   Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis [J].
Hegardt, FG .
BIOCHEMICAL JOURNAL, 1999, 338 :569-582